Skip to search formSkip to main contentSkip to account menu

AGN 194204

Known as: AGN-194204, AGN194204 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Fatty Acids, UnsaturatedTetrahydronaphthalenes

Narrower (1)

NRX 194204

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2007
Review
2007
ANew Rexinoid , NRX 194204 , Prevents Carcinogenesis in Both the Lung andMammary Gland
Purpose:We evaluated the anti-inflammatory and growth-inhibitory properties of the novel rexinoid NRX194204 (4204) in vitro and… 
2006
2006
Upregulation of Cyclooxygenases by Retinoic Acid in Rat Mesangial Cells
All-trans retinoic acid (ATRA) increases the expression of COX-1 and COX-2 and the production of PGE2, a prostaglandin with anti… 
2004
2004
Suppression of human pancreatic cancer cell proliferation by AGN194204, an RXR-selective retinoid.
Retinoids may be useful agents for the treatment of pancreatic cancer. However, retinoic acid receptor (RAR)-selective retinoids… 
Highly Cited
2004
Highly Cited
2004
Retinoic acid receptor α and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat
Retinoids, derivatives of vitamin A, inhibit mesangial cell proliferation, glomerular inflammation, and extracellular matrix… 
2002
2002
RXR receptor agonist suppression of thyroid function: central effects in the absence of thyroid hormone receptor.
High-affinity agonists for the retinoic acid X receptors (RXR) have pleotropic effects when administered to humans. These include… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)